Bottom line
How much do IHI and RYHIX overlap?
15% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 52.4% of IHI's assets and 5.6% of RYHIX's. They are substantially different portfolios, so owning both adds real diversification.
RYHIX holds far more positions (135 vs 50), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IHI and RYHIX have in common
| Holding | % of IHI | % of RYHIX | Overlap |
|---|---|---|---|
| Abbott Laboratories | 16.93% | 1.42% | 1.42% |
| Intuitive Surgical, Inc. | 15.09% | 1.31% | 1.31% |
| Stryker Corporation | 11.64% | 1.21% | 1.21% |
| Edwards Lifesciences Corporation | 4.75% | 0.84% | 0.84% |
| Boston Scientific Corporation | 3.99% | 0.86% | 0.86% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IHI
- Becton, Dickinson And Company — 4.63%
- Ge Healthcare Technologies Inc. — 4.51%
- Medtronic Public Limited Company — 4.40%
- Resmed Inc. — 4.38%
- Idexx Laboratories, Inc. — 4.27%
- Dexcom, Inc. — 4.02%
- Steris Public Limited Company — 3.20%
- Zimmer Biomet Holdings, Inc. — 2.58%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 2.15%
- Penumbra, Inc. — 1.92%
- Baxter International Inc. — 1.71%
- Insulet Corporation — 1.63%
- Globus Medical, Inc. — 1.39%
- Glaukos Corporation — 1.27%
- Teleflex Incorporated — 0.87%
Only in RYHIX
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
- Cvs Health Corp — 1.31%
- Danaher Corp — 1.30%
- Pfizer Inc — 1.25%
- Bristol-myers Squibb Company — 1.22%
- Mckesson Corp — 1.05%
- Elevance Health Inc — 1.02%
Asset mix
| Asset type | IHI | RYHIX |
|---|---|---|
| Stocks | 99.8% | 83.2% |
| Cash & short-term funds | 2.3% | — |
| Repurchase agreements | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | IHI | RYHIX |
|---|---|---|
| US | 93.5% | 73.0% |
| IE | 7.6% | 3.3% |
| CH | — | 2.3% |
| GB | 0.7% | 1.8% |
| DK | — | 1.4% |
| NL | — | 0.7% |
| IL | — | 0.6% |
| DE | — | 0.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do IHI and RYHIX overlap?
What stocks do IHI and RYHIX have in common?
Should I own both IHI and RYHIX?
Which holds more stocks, IHI or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.